Beyond the Abstract - Role of sorafenib in renal cell carcinoma: Focus on ... UroToday When we consider renal cell carcinoma, the median age of diagnosis is 65 years old. Concerning the six drugs currently approved for the treatment of kidney cancer, only a few elderly patients are enrolled in phase III registration studies.

...